Pharmacology, Toxicology and Pharmaceutical Science
Ribavirin
95%
Hepatitis C Virus
46%
Infection
43%
Liver Cirrhosis
43%
Peginterferon
35%
Chronic Hepatitis C
34%
Hepatitis C
33%
Adverse Event
33%
Boceprevir
32%
Hepatitis C Virus Genotype 1
26%
Antivirus Agent
24%
Interferon
24%
Placebo
18%
Ritonavir
15%
Liver Disease
14%
Ombitasvir
14%
Drug
14%
Simeprevir
14%
Hepatic Encephalopathy
13%
Sofosbuvir
13%
Virus RNA
12%
Clinical Trial
12%
Glecaprevir Plus Pibrentasvir
11%
Paritaprevir
11%
Proteinase Inhibitor
11%
Anemia
11%
Dasabuvir
10%
Fibrosis
9%
Daclatasvir
9%
Peginterferon Alpha
9%
Decompensated Liver Cirrhosis
9%
Relapse
8%
Nonalcoholic Fatty Liver
8%
Telaprevir
8%
Diseases
7%
Hepatitis B
7%
Fatigue
7%
Nonstructural Protein 5A Inhibitor
7%
Virus
7%
Complication
7%
Ledipasvir Plus Sofosbuvir
6%
Recurrent Disease
6%
Glecaprevir
6%
Pibrentasvir
6%
Lamivudine
6%
RNA
5%
Portal Hypertension
5%
Hepatitis B Virus
5%
Rifaximin
5%
Headache
5%
Medicine and Dentistry
Patient
100%
Therapeutic Procedure
58%
Combination Therapy
37%
Ribavirin
27%
Liver Transplantation
24%
Hepatitis C Virus
22%
Inpatient
21%
Liver Cirrhosis
19%
Nonalcoholic Fatty Liver
18%
Hepatitis C
16%
Infection
15%
Thrombocytopenia
14%
Genotype
12%
Fibrosis
12%
Interferon
12%
Chronic Hepatitis C
12%
Liver Disease
11%
Peginterferon
11%
Platelet
11%
Hepatocellular Carcinoma
10%
Hepatic Encephalopathy
10%
Adverse Event
10%
Diseases
9%
Complication
9%
Liver
9%
Chronic Liver Disease
8%
Hepatitis B
8%
Antivirus Agent
8%
Liver Biopsy
7%
Development
7%
Health Care Cost
7%
Boceprevir
7%
Portal Hypertension
7%
Ritonavir
6%
Diagnosis
6%
Transplantation
6%
Recurrent Disease
6%
Hepatitis B Virus
5%
Tioguanine
5%
Decompensated Liver Cirrhosis
5%
Ombitasvir
5%
Prevalence
5%
Hepatitis C Virus Genotype 1
5%
Relapse
5%
Odds Ratio
5%
Dasabuvir
5%
Nursing and Health Professions
Patient
50%
Ribavirin
22%
Sustained Virologic Response
17%
Combination Therapy
14%
Liver Cirrhosis
12%
Hepatitis C
12%
Infection
11%
Chronic Hepatitis C
10%
Inpatient
6%
Treatment Duration
6%
Peginterferon
5%
Boceprevir
5%
Ritonavir
5%
Adverse Event
5%